Heart, Lung and Circulation
Brief Communication| Volume 20, ISSUE 4, P234-236, April 2011

Adjuvant Therapy with Methylene Blue in the Treatment of Right Ventricular Failure after Pulmonary Embolectomy

      Severe pulmonary embolism often leads to right ventricular failure after surgical embolectomy secondary to ischaemia reperfusion injury and acute lung injury (ALI). Acute right ventricular dysfunction is traditionally treated with inotropes and vasopressors to maintain cardiac output and coronary perfusion as well as selective pulmonary vasodilators to provide right ventricular afterload reduction. We report the first case of utilisation of methylene (MB) in a patient with acute right ventricular failure and vasoplegic shock after surgical pulmonary embolectomy.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Heart, Lung and Circulation
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Leyh R.G.
        • Kofidis T.
        • Struber M.
        • Fischer S.
        • Knobloch K.
        • Wachsmann B.
        • et al.
        Methylene blue: the drug of choice for catecholamine refractory vasoplegia after cardiopulmonary bypass?.
        J Thorac Cardiovasc Surg. 2003; 125: 1426-1431
        • Friedrich M.
        • Brauer A.
        • Tirilomis T.
        • Lotfi S.
        • Mielck F.
        • Busch T.
        Methylene blue administration in severe systemic inflammation response syndrome (SIRS) after thoracic surgery.
        Ann Thorac Cardiovasc Surg. 2002; 8: 306-310
        • Kirov M.Y.
        • Evgenov O.V.
        • Evgenov N.V.
        • Sovershaev M.A.
        • Sveinbjϕrnsson B.
        • Nedashkovsky E.V.
        Infusion of methylene blue in human septic shock: a pilot, randomized, controlled study.
        Crit Care Med. 2001; 29: 1860-1867
        • Stein M.
        • Levy S.E.
        Reflex and humoral responses to pulmonary embolism.
        Prog Cardiovasc Dis. 1974; 17: 167-174
        • Malik A.B.
        Pulmonary microembolism.
        Phystol Rev. 1983; 63: 1114-1207
        • Taylor R.R.
        • Covell J.W.
        • Sonnenblick E.H.
        • Ross Jr., J.
        Dependence of ventricular distensibility on filling of the opposite ventricle.
        Am J Physiol. 1967; 213: 711-718
        • Lualdi J.C.
        • Goldhaber S.Z.
        Right ventricular dysfunction after acute pulmonary embolism: pathophysiologic factors, detection, and therapeutic implications.
        Am Heart J. 1995; 130: 1276-1282
        • Preiser J.C.
        • Lejeun P.
        • Roman A.
        • Carlier E.
        • De Backer D.
        • Leeman M.
        • et al.
        Methylene blue administration in septic shock: a clinical trial.
        Crit Care Med. 1995; 23: 259-264
        • Donati A.
        • Conti G.
        • Loggi S.
        • Munch C.
        • Coltrinari R.
        • Pelaia P.
        • et al.
        Does methylene blue administration to septic shock patients affect vascular permeability and blood volume?.
        Crit Care Med. 2002; 30: 2271-2277
        • Ozal E.
        • Kuralay E.
        • Yildirim V.
        • Kilic S.
        • Bolcal C.
        • Kucukarslan N.
        • et al.
        Preoperative methylene blue administration in patients at high risk for vasoplegic syndrome during cardiac surgery.
        Ann Thorac Surg. 2005; 79: 1615-1619
        • Levin R.L.
        • Degrange M.A.
        • Bruno G.F.
        • Del Mazo C.D.
        • Taborda D.J.
        • Griotti J.J.
        • et al.
        Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery.
        Ann Thorac Surg. 2004; 77: 496-499
        • Gachot B.
        • Bedos J.P.
        • Veber B.
        • Wolff M.
        • Regnier B.
        Short-term effects of methylene blue on hemodynamics and gas exchange in humans with septic shock.
        Intensive Care Med. 1995; 21: 1027-1031
        • Kofidis T.
        • Struber M.
        • Wilhelmi M.
        • Anssar M.
        • Simon A.
        • Harringer W.
        • et al.
        Reversal of severe vasoplegia with single-dose methylene blue after heart transplantation.
        J Thorac Cardiovasc Surg. 2001; 122: 823-824
        • Sitbon O.
        • Brenot F.
        • Denjean A.
        • Bergeron A.
        • Parent F.
        • Azarian R.
        • et al.
        Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclin.
        Am J Respir Crit Care Med. 1995; 151: 384-389
        • Rossaint R.
        • Falke K.J.
        • Lopez F.
        • Slama K.
        • Pison U.
        • Zapol W.M.
        Inhaled nitric oxide for the adult respiratory distress syndrome.
        N Engl J Med. 1993; 328: 399-405
        • Capellier G.
        • Jacques T.
        • Balvay P.
        • Blasco G.
        • Belle E.
        • Barale F.
        Inhaled nitric oxide in patients with pulmonary embolism.
        Intensive Care Med. 1997; 23: 1089-1092